Loading...
Loading...
According to Auriga, athenahealth
ATHN price target is raised to $57.
Auriga said that it is reiterating its HOLD rating on athenahealth (
ATHN) following an inline quarter in which revenue and doctor adds were largely consistent with our expectations. “We are raising our price target to $57 from $47 as we look out to FY13, but meanwhile find current levels too rich for our comfort.”
athenahealth closed yesterday at $66.03.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in